Paradigm Financial Partners, LLC Bristol Myers Squibb CO Transaction History
Paradigm Financial Partners, LLC
- $894 Million
- Q2 2025
A detailed history of Paradigm Financial Partners, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Paradigm Financial Partners, LLC holds 11,073 shares of BMY stock, worth $510,133. This represents 0.06% of its overall portfolio holdings.
Number of Shares
11,073
Previous 11,281
1.84%
Holding current value
$510,133
Previous $688,000
25.58%
% of portfolio
0.06%
Previous 0.09%
Shares
28 transactions
Others Institutions Holding BMY
# of Institutions
2,668Shares Held
1.64BCall Options Held
22.5MPut Options Held
25.3M-
Vanguard Group Inc Valley Forge, PA195MShares$8.98 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.31 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.98 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.36 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.26 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $98B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...